New combo therapy for head and neck cancer: what are the skin risks?
NCT ID NCT01647555
First seen Mar 20, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looked at skin problems in 57 adults with advanced head and neck cancer who received radiation therapy along with the drug cetuximab. The main goal was to track and understand skin side effects from this combination treatment. Researchers also measured quality of life and how well the tumors responded.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMOID HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Bourgogne
Lille, 59000, France
-
Centre Galilée
Lille, 59045, France
-
Centre Gray
Maubeuge, 59600, France
-
Centre Joliot Curie
Saint-Martin-Boulogne, 62280, France
-
Centre Leonard de Vinci
Douai, 59500, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Clinique du Parc
Croix, 599962, France
Conditions
Explore the condition pages connected to this study.